Healthcare
American Stroke Month Highlights B.E. F.A.S.T. Signs as Minutes Matter in Stroke Response
The American Stroke Association urges recognition of stroke signs using B.E. F.A.S.T., emphasizing that quick action can save brain cells and reduce disability, as nearly 80% of strokes are preventable through risk factor management.
Aquinas Senior Living Achieves 99.8% Resident Adoption of Teton AI Monitoring Across Pennsylvania Portfolio
Aquinas Senior Living has scaled Teton's AI-powered monitoring platform across its Pennsylvania communities, achieving near-universal resident adoption and integrating an E-call system to unify fall detection and assistance requests.
House Hearing Scrutinizes Hospital CEOs Over High Facility Fees
A House Ways and Means Committee hearing put hospital CEOs on the spot for excessive facility fees, raising questions about healthcare affordability and insurer challenges.
BioStem Technologies to Report First Quarter 2026 Results on May 14
BioStem Technologies will release Q1 2026 financial results on May 14, 2026, followed by a conference call and webcast at 4:30 PM ET, offering investors insight into the company's performance and growth trajectory in regenerative medicine.
BioVersys Shareholders Approve All Board Proposals, Including New Board Member and Compensation Packages
BioVersys AG announced that shareholders approved all board proposals at its annual general meeting, including the re-election of directors and election of a new board member, as the company advances its lead antibiotic candidate into Phase 3 trials.
Cardio Diagnostics Targets Precision Cardiology with Multi-Omic AI Platform
Cardio Diagnostics Holdings (NASDAQ: CDIO) leverages AI to integrate epigenetic and genetic biomarkers for personalized cardiovascular risk assessments, potentially transforming disease prevention and treatment.
Oncotelic Therapeutics Advances AI and Robotics Platform Toward Initial Commercial Deployment
Oncotelic Therapeutics reports progress on its proprietary AI platform and robotics integration, aiming to improve efficiency and compliance in pharmaceutical development and manufacturing.
Telomir Pharmaceuticals Gains FDA Clearance for Telomir-Zn Phase 1/2 Trial in Triple-Negative Breast Cancer
Telomir Pharmaceuticals announced FDA IND clearance for Telomir-Zn to treat advanced triple-negative breast cancer, allowing a Phase 1/2 trial to proceed and marking a key step toward clinical development.
HeartBeam to Report Q1 Earnings, Update on Commercial Launch and AI Initiatives
HeartBeam Inc. will host a Q1 2026 earnings call to discuss financial results and provide updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, and AI programs, marking a pivotal moment for the company's cardiac care innovations.
NeuroOne Announces CFO Succession Plan as Ron McClurg Retires, Chris Volker Takes Over
NeuroOne Medical Technologies Corporation announced that CFO Ron McClurg will retire effective June 30, 2026, with current COO Chris Volker assuming the permanent CFO role, ensuring a smooth transition as the company advances its growth strategy.
BioStem Appoints Katherine Gorrell as Chief Legal & Compliance Officer, Signaling Growth and Nasdaq Uplisting Ambitions
BioStem Technologies strengthens its leadership by appointing Katherine Gorrell, a seasoned legal and compliance executive, to oversee governance and regulatory strategy as the company pursues a Nasdaq uplisting.
Aclarion Reports 196% Surge in Nociscan Scans, Advances Reimbursement and Clinical Trials
Aclarion's Q1 2026 results show a 196% year-over-year increase in Nociscan scan volumes, driven by clinical adoption and payer coverage, with a strong cash position and upcoming CLARITY trial data expected in late 2026.
American Heart Association Warns Health Care Affordability Reaches Crisis Level, Outlines Principles for Reform
The American Heart Association's new Presidential Advisory declares U.S. health care affordability a crisis, citing nearly $5 trillion in annual spending and proposing five core principles to guide policy changes.
Earth Science Tech Leverages Vertical Integration to Target Precision Medicine Market
Earth Science Tech Inc. (ETST) is building a vertically integrated healthcare platform combining compounding pharmacy, telemedicine, and clinical services to capitalize on the growing precision medicine market.
Why Waiting to Plan Senior Care Costs More Than You Think
Delaying senior care planning until a crisis forces decisions can lead to higher costs, limited options, and emotional strain; proactive financial and care planning offers families more control and predictability.
Stopping the ‘Silent Killer’: How to Check, Prevent and Manage High Blood Pressure
American Heart Association highlights that nearly half of U.S. adults have high blood pressure, many undiagnosed, and emphasizes lifestyle changes and monitoring to prevent heart disease and stroke.
Regeneris Launches Flexlift™, an Office-Based Face and Neck Lift with Minimal Downtime
Regeneris introduces Flexlift™, a face and neck rejuvenation procedure developed by Dr. Edwin Ishoo that uses local anesthesia, reduces recovery time, and costs less than traditional facelifts.
Tonix Pharmaceuticals Advances Lyme Disease Prevention with Phase 1 Data and Plans for Phase 2 Study
Tonix Pharmaceuticals reported Phase 1 data for its Lyme disease prevention candidate TNX-4800 and announced plans for an adaptive Phase 2 field study, highlighting the unmet need for prophylactic options in the U.S.
MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology
MindBio Therapeutics has filed patent applications for its AI-driven voice technology that detects drug and alcohol intoxication, with commercial kiosks for mining and aviation on track for delivery by Q2 2026.
International Healthcare Week Returns to Hong Kong, Reinforcing City's Role as MedTech and Investment Hub
The fifth International Healthcare Week, featuring the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair, aims to solidify Hong Kong's position as a leading biotech and investment hub while aligning with China's 15th Five-Year Plan priorities.
Lantern Pharma Expands predictBBB Platform into Large Quantitative Model for Drug Discovery
Lantern Pharma announced the expansion of its predictBBB platform into a Large Quantitative Model (LQM), enabling real-time molecular intelligence for drug discovery, which could accelerate development and reduce costs.
NextPlat Corp Reports Turnaround Progress with Improved Margins and Path to Profitability
NextPlat Corp (NASDAQ: NXPL) announces lower operating expenses and improved margins in Q1 2026, targeting positive operating income by Q3 2026, driven by higher-margin healthcare services and a strong balance sheet.
VolitionRx Achieves Technical Milestone in Sepsis Detection with Finger-Prick Prototype
VolitionRx announced a prototype that can detect nucleosomes in capillary blood from sepsis patients, potentially enabling point-of-care testing and expanding access in regions with limited lab infrastructure.
GeoVax Advances Gedeptin Toward Phase 2 Initiation and Strategic Partnership Opportunities
GeoVax Labs outlines near-term milestones for its oncology candidate Gedeptin, including a planned Phase 2 trial in head and neck cancer, as it seeks combination therapy partnerships.
LakeShore Biopharma Amends Merger Agreement, Slashes Share Consideration to $0.066 in Going-Private Deal
LakeShore Biopharma has amended its merger agreement to take the company private at a reduced equity value of $2.7 million, offering $0.066 per share after a revised proposal from the buyer group.
BioAdaptives Launches MyndSystem Platform to Target Cognitive Performance and Recovery
BioAdaptives, Inc. launched MyndSystem, a dual-phase cognitive support platform with daytime and nighttime formulations, aiming to enhance focus, clarity, sleep quality, and neurological recovery, positioning it as a long-term growth driver.
MindBio Therapeutics Develops AI-Powered Voice Analysis for Non-Invasive Drug and Alcohol Detection
MindBio Therapeutics is launching an AI-driven voice analysis technology to detect impairment, targeting a growing $4.2 billion testing market and offering a less invasive alternative to traditional methods.
Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
Littleton Dental Practice Expands Focus on Anxiety-Free Care, Citing Patient Fear as Barrier to Routine Visits
Southbridge Dentistry in Littleton, Colorado has announced an expanded emphasis on sedation and comfort protocols to address dental anxiety, a move that reflects a broader trend in patient-centered care and could increase routine dental visits among fearful patients.
Cherry Hill Dentist Highlights Dental Implants as Preferred Long-Term Tooth Replacement Option
Omega Dental Arts in Cherry Hill, NJ, emphasizes dental implants over bridges and dentures due to their structural advantages and high patient satisfaction, marking a strategic shift in restorative dentistry communication.